From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,810,000 shares, representing 6.03% for $74.32 million under the buyback announced on March 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.39 USD | +1.18% | -3.26% | -26.01% |
05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.01% | 640M | |
-23.69% | 7.86B | |
+2.10% | 2.63B | |
-8.06% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.18% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B | |
+15.82% | 957M |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.